C
Capcium
A privately-owned Montreal-based global leader in softgel manufacturing
About Capcium
Capcium is a Canadian company specializing in the manufacturing of high-quality softgel capsules. Serving clients in the pharmaceutical, nutraceutical, cosmetic, and cannabis sectors, Capcium provides a comprehensive range of encapsulation services. The company operates in a highly specialized market, offering precision-focused, pharmaceutical-grade manufacturing that meets the specific needs of its diverse clientele. Capcium's business model revolves around contract manufacturing, where they produce softgel capsules for other companies, ensuring consistent quality and dosage. Their revenue is generated through these manufacturing contracts, which include formulation and process development services. Capcium's expertise in encapsulation technology allows them to help clients bring their products to market quickly and efficiently. The company is known for its exacting standards and ability to open new market opportunities for its clients by transforming their molecules into effective softgel formats.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2012
- Headquarters
- St. Louis, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Cannabis, Health Supplements, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2018 | $10M | $40M | Aurora Cannabis | — |
Growth signals
Latest recorded traffic for Capcium is 100 monthly website visits, down 9.1% over the last three months. Capcium's team declined 42.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Aurora Cannabis
Other known investors1 additional known investor
Fulcrum Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Capcium on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Capcium’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.